China Literature (CHLLF) Short Interest Ratio & Short Volume → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free CHLLF Stock Alerts $3.25 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartShort InterestStock AnalysisChartShort Interest China Literature Short Interest DataCurrent Short Interest2,503,900 sharesPrevious Short Interest2,311,300 sharesChange Vs. Previous Month+8.33%Dollar Volume Sold Short$8.13 millionShort Interest Ratio544.3 Days to CoverLast Record DateApril 30, 2024Today's Trading Volume0 sharesAverage Trading Volume244 sharesToday's Volume Vs. Average0% Short Selling China Literature ? Sign up to receive the latest short interest report for China Literature and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCHLLF Short Interest Over TimeCHLLF Days to Cover Over TimeCHLLF Percentage of Float Shorted Over Time Ad Stansberry ResearchA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here. China Literature Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,503,900 shares $8.13 million +8.3%N/A544.3 $3.25 4/15/20242,311,300 shares $7.50 million +5.6%N/A2311.3 $3.25 3/31/20242,188,500 shares $7.10 million -21.9%N/A21885 $3.25 3/15/20242,801,900 shares $9.23 million -11.9%N/A0 $3.29 2/29/20243,181,900 shares $10.48 million +29.0%N/A0 $3.29 2/15/20242,467,100 shares $8.13 million -7.1%N/A0 $3.29 Get the Latest News and Ratings for CHLLF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for China Literature and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,307,700 shares $7.60 million +20.5%N/A0 $3.29 12/31/20231,915,900 shares $6.31 million -19.3%N/A2649.9 $3.29 12/15/20232,374,300 shares $7.82 million -23.6%N/A23743 $3.29 11/30/20233,107,100 shares $10.33 million +8.1%N/A0 $3.32 11/15/20232,875,100 shares $9.56 million +10.8%N/A0 $3.32 10/31/20232,596,100 shares $8.63 million -20.4%N/A0 $3.32 10/15/20233,260,100 shares $10.84 million +2.7%N/A0 $3.32 9/30/20233,173,500 shares $10.55 million +15.2%N/A31735 $3.32 9/15/20232,754,700 shares $11.74 million +1.0%N/A5509.4 $4.26 8/31/20232,726,700 shares $11.62 million +20.6%N/A85210.3 $4.26 8/15/20232,260,300 shares $8.84 million +12.0%N/A22603 $3.91 7/31/20232,019,100 shares $8.04 million +51.1%N/A20191 $3.98 7/15/20231,336,700 shares $6.19 million +26.4%N/A0 $4.63 6/30/20231,057,500 shares $4.90 million -5.9%N/A10575 $4.63 6/15/20231,124,300 shares $5.06 million -56.5%N/A11243 $4.50 5/31/20232,583,900 shares $14.02 million -13.6%N/A0 $5.43 5/15/20232,991,000 shares $16.23 million -9.4%N/A0 $5.43 4/30/20233,302,800 shares $17.92 million +26.8%N/A0 $5.43 4/15/20232,604,500 shares $14.13 million -1.6%N/A2604.5 $5.43 3/31/20232,646,500 shares $14.36 million -19.6%N/A26465 $5.43 3/15/20233,292,200 shares $14.91 million -3.4%N/A32922 $4.53 2/28/20233,406,700 shares $15.43 million -18.2%N/A0 $4.53 2/15/20234,163,100 shares $10.24 million +90.6%N/A41631 $2.46 1/31/20232,184,100 shares $5.37 million -4.2%N/A0 $2.46 1/15/20232,279,300 shares $5.61 million +35.9%N/A22793 $2.46 12/30/20221,677,000 shares $4.13 million +77.3%N/A0 $2.46 12/15/2022945,800 shares $2.33 million -18.9%N/A0 $2.46 11/30/20221,166,000 shares $2.87 million -30.7%N/A2332 $2.46 11/15/20221,682,200 shares $4.14 million -34.6%N/A0 $2.46 10/31/20222,573,200 shares $6.33 million +10.8%N/A1838 $2.46 10/15/20222,323,200 shares $5.72 million +6.7%N/A203.8 $2.46 9/30/20222,178,400 shares $8.84 million +21.4%N/A2178.4 $4.06 9/15/20221,793,800 shares $7.28 million +83.8%N/A1195.9 $4.06 8/31/2022975,800 shares $3.96 million +50.6%N/A487.9 $4.06**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 8/15/2022648,000 shares $2.63 million -5.8%N/A381.2 $4.06 7/31/2022687,800 shares $2.79 million -16.4%N/A0 $4.06 7/15/2022822,600 shares $3.34 million -4.2%N/A632.8 $4.06 6/30/2022858,400 shares $3.90 million +1.6%N/A4292 $4.54 6/15/2022845,200 shares $3.54 million +7.2%N/A8452 $4.19 5/31/2022788,400 shares $3.14 million -30.0%N/A0 $3.99 5/15/20221,127,000 shares $4.50 million -2.1%N/A281.8 $3.99 4/30/20221,150,800 shares $4.78 million +6.2%N/A11508 $4.15 4/15/20221,083,600 shares $4.48 million -30.1%N/A0 $4.13 3/31/20221,549,600 shares $6.40 million +13.3%N/A774.8 $4.13 3/15/20221,367,400 shares $8.06 million -2.1%N/A976.7 $5.89 2/28/20221,397,200 shares $8.23 million +35.3%N/A191.4 $5.89 2/15/20221,032,400 shares $6.38 million +13.0%N/A0 $6.18 1/31/2022913,600 shares $5.65 million -7.0%N/A0 $6.18 1/15/2022982,000 shares $6.07 million +0.5%N/A178.5 $6.18 12/31/2021977,200 shares $6.06 million +30.3%N/A3257.3 $6.20 12/15/2021750,000 shares $5.85 million -18.3%N/A1250 $7.80 11/30/2021918,200 shares $7.16 million +10.9%N/A0 $7.80 11/15/2021827,800 shares $6.46 million +1.4%N/A8278 $7.80 10/29/2021816,300 shares $6.37 million -0.7%N/A8163 $7.80 10/15/2021821,700 shares $6.33 million +1.7%N/A0 $7.70 9/30/2021807,900 shares $6.22 million -25.3%N/A0 $7.70 9/15/20211,081,700 shares $8.33 million -17.2%N/A10817 $7.70 8/31/20211,306,300 shares $10.06 million -10.3%N/A6531.5 $7.70 8/13/20211,455,500 shares $13.10 million -8.2%N/A14555 $9.00 7/30/20211,585,500 shares $17.44 million +38.7%N/A0 $11.00 7/15/20211,143,300 shares $12.58 million +38.9%N/A0 $11.00 6/30/2021822,900 shares $9.05 million +32.6%N/A8229 $11.00 6/15/2021620,700 shares $6.66 million +6.1%N/A6207 $10.73 5/28/2021585,000 shares $6.14 million +46.3%N/A975 $10.50 5/14/2021400,000 shares $3.64 million +14.4%N/A0 $9.10 4/30/2021349,800 shares $3.18 million -18.9%N/A1166 $9.10 4/15/2021431,300 shares $3.92 million -55.9%N/A0 $9.10 3/31/2021978,300 shares $8.90 million -49.3%N/A0 $9.10 3/15/20211,928,100 shares $17.55 million -15.0%N/A19281 $9.10 2/26/20212,268,700 shares $18.60 million -6.9%N/A0 $8.20 2/12/20212,436,100 shares $19.98 million -24.3%N/A0 $8.20 1/29/20213,219,400 shares $26.40 million -6.6%N/A10731.3 $8.20 1/15/20213,043,800 shares $22.37 million +3.2%N/A7609.5 $7.35 12/31/20203,057,600 shares $22.47 million +0.5%N/A10192 $7.35 12/15/20203,043,800 shares $22.86 million +3.2%N/A7609.5 $7.51 11/30/20202,949,200 shares $21.82 million -0.7%N/A0 $7.40 11/15/20202,969,300 shares $21.97 million -1.1%N/A14846.5 $7.40 10/30/20203,002,700 shares $23.27 million +3.8%N/A0 $7.75 10/15/20202,893,300 shares $22.42 million -1.6%N/A3214.8 $7.75 9/30/20202,940,800 shares $21.91 million -4.5%N/A7352 $7.45 9/15/20203,079,300 shares $19.25 million +97.7%N/A30793 $6.25 8/31/20201,557,700 shares $9.35 million +42.5%N/A15577 $6.00 8/14/20201,093,000 shares $360,690.00 0.0%N/A2186 $0.33 7/31/20201,093,400 shares $306,261.34 +4.0%N/A1366.8 $0.28**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report 7/15/20201,051,800 shares $220,878.00 +59.2%N/A5259 $0.21 6/30/2020660,800 shares $4.42 million +373.4%N/A1652 $6.69 6/15/2020139,600 shares $0.00 -52.5%N/A60.7 $0.00 5/29/2020294,000 shares $1.97 million -75.9%N/A490 $6.69 5/15/20201,220,000 shares $6.10 million -18.8%N/A2033.3 $5.00 4/30/20201,502,600 shares $7.51 million -8.6%N/A3005.2 $5.00 4/15/20201,644,600 shares $0.00 -16.1%N/A357.5 $0.00 3/31/20201,960,000 shares $7.64 million -20.2%N/A220.2 $3.90 3/13/20202,455,600 shares $9.58 million -9.5%N/A0 $3.90 2/28/20202,712,000 shares $0.00 -0.5%N/A271.2 $0.00 2/14/20202,726,100 shares $11.59 million -30.4%N/A5452.2 $4.25 1/31/20203,916,600 shares $0.00 -5.8%N/A9791.5 $0.00 1/15/20204,156,600 shares $18.08 million +2.6%N/A41566 $4.35 12/31/20194,053,200 shares $0.00 +24.1%N/A4503.6 $0.00 CHLLF Short Interest - Frequently Asked Questions What is China Literature's current short interest? Short interest is the volume of China Literature shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,503,900 shares of CHLLF short. Learn More on China Literature's current short interest. What is a good short interest ratio for China Literature? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CHLLF shares currently have a short interest ratio of 544.0. Learn More on China Literature's short interest ratio. Is China Literature's short interest increasing or decreasing? China Literature saw a increase in short interest in April. As of April 30th, there was short interest totaling 2,503,900 shares, an increase of 8.3% from the previous total of 2,311,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short China Literature stock? Short selling CHLLF is an investing strategy that aims to generate trading profit from China Literature as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against China Literature? A short squeeze for China Literature occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CHLLF, which in turn drives the price of the stock up even further. How often is China Literature's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHLLF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ADEVF Short Interest BBTVF Short Interest BZFDW Short Interest CSXXY Short Interest CTTMF Short Interest CCGWW Short Interest DELCF Short Interest DATI Short Interest DHGAF Short Interest HMNTY Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CHLLF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts